FINDLAY, Ohio (WCMH) — Nearly 40 percent of all Americans will be diagnosed with cancer at some point during their lifetimes.
Now, pharmacy students at a college here in Ohio believe they have found a drug to target the most aggressive form of the disease.
Glioblastoma is cancer that develops in the brain or spinal cord and is nearly impossible to remove.
Experts say the five-year survival rate is less than 10 percent.
Researchers at the University of Findlay may have created a drug to improve that statistic.
It’s from a compound found in Indian curry called Chalcone.
Researchers say it selectivity targets only the brain cancer cells while sparing the healthy cells.
“Selectivity is the holy grail of cancer therapy because we know that chemotherapy has a lot of side effects, so how do we achieve that selectivity where our compounds can only kill brain cancer, glioblastoma, and spare the normal brain,” said Dr. Rahul Khupse, a medicinal chemist at the College of Pharmacy with the University of Findlay.
Experts say it typically takes 10 to 15 years for a new drug to get from the lab to the patient.
More headlines from CBS17.com:
- Report: U.S. Postal Service warns 46 states about mail voting delays including North Carolina
- This NC woman turned 116 and is the oldest person in the U.S.
- Durham residents want peace as police adjust to combat surge in gun violence
- Students concerned after COVID-19 clusters confirmed at UNC housing
- Despite cancellation, dozens turn out for vigil honoring Cannon Hinnant
For more stories like this that matter to you, click here to download the CBS 17 News app for free.
Watch live newscasts, get breaking news and sign up for push alerts – download now